CareDx Inc. (CDNA)

28.15 +1.57 (+5.907%)

IEX Real-Time Price

September 25, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 26.58

Price Open 26.55

Volume: 760,431

Avg Volume: 764,172

Market Cap: 1.02B

P/E Ratio -51.18

52 Wk Range 3.39-28.46



CDNA Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-08-31
34.19M
1.49M
2.57
4.36%

2018-08-15
34.16M
2.48M
6.49
7.26%

2018-07-31
33.5M
2.52M
8.04
7.51%

2018-07-13
33.5M
2.83M
2.38
8.44%




CDNA Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-06-08
Q1 2018
N/A
-0.14 (2)
-0.16
-0.09

2018-05-10
Q1 2018
AMC
-0.13 (1)
-0.16
-0.09

2018-04-20
Q4 2017
N/A
-0.15 (3)
-0.16
-0.09

2018-03-22
Q4 2017
AMC
-0.15 (3)
-0.16
-0.09

News

Canaccord bullish on medical diagnostic firms (2018-09-14 08:22 SeekingAlpha)

In a note, Canaccord's Mark Massaro says diagnostic companies are outperforming this year, with CareDx (NASDAQ: CDNA ) and Foundation Medicine (NASDAQ: FMI )(acquired by Roche) leading the way. More news on: CareDx, Foundation Medicine, Inc., HTG Molecular Diagnostics, Healthcare stocks ne…

 


Statistics

Shares Outstanding: 36.35M

Top 15 Institution Percent: 73.50

Price To Sales: 16.67

Price To Book: 32.58

Revenue: 12.19M

Gross Profit: 6.98M

Cash: 5.98M

Debt: 36.20M

Return On Assets: -86.55

Return On Equity: -336.02

Profit Margin: N/A

Price History

Beta: 0.88

50-day Moving Avg: 19.01

200-day Moving Avg: 11.41

YTD Change: N/A

5-day Change: -2.06

1-month Change: 25.38

3-month Change: 122.06

6-month Change: N/A

1-year Change: N/A

Revenue Per Share: 0.00

Revenue Per Employee: 68106.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: CareDx Inc.

Exchange: NASDAQ Global Market

Industry: Medical Diagnostics & Research

Sector: Healthcare

Website: http://www.xdx.com

CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.